TPU PHARMA
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90980667
- Registration number
- 7270464
- Mark type
- Stylized text
- Filed
- 12 Oct 2020
- Published for opposition
- 23 Mar 2021
- Registered
- 09 Jan 2024
- Attorney of record
- Bret E. Field
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics
Owner
- Teikoku Pharma USA, Inc., San Jose, CA, US
- Teikoku Pharma USA, Inc., San Jose, CA, US
- Teikoku Pharma USA, Inc., San Jose, CA, US
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Nov 2023 — USE AMENDMENT FILED
- 01 Dec 2023 — DIVISIONAL PROCESSING COMPLETE
- 29 Nov 2023 — DIVISIONAL REQUEST RECEIVED
- 14 Nov 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 27 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 11 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2023 — SOU EXTENSION 4 GRANTED
- 09 May 2023 — SOU EXTENSION 4 FILED
- 09 May 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED